Private · Company · Aksjeselskap
Pre Vention AS
917 734 453 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
Activitylast 24 mo
No job-ad activity on file
totals on file · ads-over-time series not yet in Intelligo
Registry changes
Accounts filed · sisteInnsendteAarsregnskap2024 → 20252026-06-24
NAV + JobStream · company_hiring · Brreg · company_changes
Timelineall sources
accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Registry · 2026-06-24
Audit opinionNo auditor's report is included; the company has resolved that the annual accounts shall not be audited. — Selskapet har besluttet at ars...Annual report · 2025-12-31
Going concernThe accounts are prepared on a going concern basis, and the board states the company is secured continued operation as it has no external...Annual report · 2025-12-31
OtherThe company has no active operations after the described situation. — Selskapet har etter dette ingen aktiv virksomhet.Annual report · 2025-12-31
Sale processThe board is considering whether the company should receive new business, be liquidated, or be merged into the parent Pre Diagnostics AS....Annual report · 2025-12-31
Staff numbersThe company has no employees, and the notes state 0.00 man-years in the financial year. — Det er ingen ansatte i selskapet.Annual report · 2025-12-31
RemunerationNo salary or other remuneration was paid to the board, and no loans or security were given to the board. — Det er ikke utbetalt lonn elle...Annual report · 2025-12-31
Share capitalShare capital consists of 30,000 ordinary shares of NOK 1 and 10,000 B-shares of NOK 1, in total 40,000 shares of NOK 1. — Selskapskapita...Annual report · 2025-12-31
OwnershipPre Diagnostics AS holds 30,000 ordinary shares (75.00%) and 2,500 B-shares (6.25%), with other B-shareholders including S. Uglestad Inve...Annual report · 2025-12-31
Post balance sheet eventIn March 2026 Pre Diagnostics AS acquired 1,250 B-shares from Hathon Invest AS. — I mars 2026 har Pre Diagnostics AS ervervet 1 250 B-aks...Annual report · 2025-12-31
Related partyThe company has a receivable of NOK 930,000 on its parent Pre Diagnostics AS (NOK 980,000 in 2024). — Pre Diagnostics AS (mor) 930 000 ...Annual report · 2025-12-31
Related partyThe parent Pre Diagnostics AS has, up to and including 2024, paid external patent costs also covering intervention-based rights licensed ...Annual report · 2025-12-31
Deferred taxThe deferred tax asset of NOK 241,654 on the loss carryforward is not capitalised, in accordance with small-entity accounting rules. — I ...Annual report · 2025-12-31
Staff numbersThe company has no employees and reported zero man-years for the year. — Det er ingen ansatte i selskapet.Annual report · 2023-12-31
RemunerationNo salary or other remuneration was paid to the board, and no loans or security were provided to the board. — Det erikkeutbetaltlonn elle...Annual report · 2023-12-31
Going concernThe accounts are prepared on a going-concern basis; the company states its cash at end-2023 covers all planned activities and it has no d...Annual report · 2023-12-31
Going concernThe board concludes continued operations are secured for the foreseeable future. — dermed sikret videre drift i overskuelig fremtid.Annual report · 2023-12-31
OwnershipShare capital consists of 30 000 ordinary shares of NOK 1 and 10 000 B-shares of NOK 1, i.e. 40 000 shares in total. — Selskapskapitalen ...Annual report · 2023-12-31
Share capitalTotal share capital is NOK 40 000 divided among the listed shareholders. — a kr.1 til sammen 40.000 aksjer a kr.1 fordelt pa folgende:Annual report · 2023-12-31
Related partyThe company holds a receivable of NOK 900 000 on its parent Pre Diagnostics AS. — Pre Diagnostics AS(mor) 900 000 900000Annual report · 2023-12-31
Related partyParent Pre Diagnostics AS has up to and including 2023 paid external patent costs also covering the company's intervention rights, licens...Annual report · 2023-12-31
Related partyThese patent costs may later, by separate agreement, be re-invoiced to Pre Vention AS. — viderefakturert tilPreVentionASAnnual report · 2023-12-31
Deferred taxThe deferred tax asset of NOK 235 054 on the loss carryforward is not capitalised, applying the small-company rules. — I samsvar med GRS ...Annual report · 2023-12-31
Audit opinionNo auditor's report is included in the filing; the company's accounts are not audited. — Selskapet har besluttet at arsregnskapet ikke s...Annual report · 2023-12-31
Audit opinionThe company has decided that the annual accounts shall not be audited, so no auditor's report is present. — Selskapet har besluttet at ar...Annual report · 2021-12-31
Going concernThe accounts are prepared on a going concern basis, with cash at year-end covering all planned costs. — Regnskapet ersattopp underforutse...Annual report · 2021-12-31
Share capitalShare capital consists of 30,000 ordinary shares of NOK 1 and 10,000 B-shares of NOK 1, in total 40,000 shares. — Selskapskapitalen besta...Annual report · 2021-12-31
OwnershipPre Diagnostics AS holds 30,000 ordinary shares equal to 75.00 percent of the company. — Pre Diagnostics AS 30 000 Ord.aksjer 75,00 %Annual report · 2021-12-31
SubsidiaryThe company owns a 35 percent stake in the associated company Lactate AS, Oslo, carried at NOK 10,500. — Lactate AS 10 500 10 500 Oslo ...Annual report · 2021-12-31
RemunerationThe company has no employees and thus no salary or remuneration paid. — Det er ingen ansatte i selskapet.Annual report · 2021-12-31
Skiwo · company_events
Job ads on NAV Arbeidsplassen12 MO
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
LocationOslo
Oslo
municipality only · street address + coordinates not yet in Intelligo
Brreg · registered municipality